Four years ago, I was pretty impressed by a new probiotic with some really compelling clinical research,

specifically relating to type 2 diabetes.

The company has been busy since then, but their focus appears to have shifted a bit from science to sales.

Today, my update on pendulum probiotics.

Hello and welcome to the Nutrition Diva podcast, a show where we take a closer look at

nutrition research and trends and answer your food and nutrition questions so that you can make more informed

choices about what you eat. I'm your host, Monica Reinagle, and today's show, like so many

others, was prompted by an email that I got from a listener, just like you. Emily wrote to

ask my opinion about a company called Pendulum. They have probiotics that supposedly

assist with glucose control and weight loss, she wrote. I just want to know if it's legitimate.

Well, as it happens, I actually profiled this company back in 2021 when they introduced their

flagship product because I thought the science behind it was quite

impressive. Unlike the vast majority of probiotic supplements on the shelves these days,

Pendulam's glucose control formula had solid research to support its effectiveness in improving

blood sugar control in people with type 2 diabetes.

Emily's email got me curious about what might have happened in the meantime.

So I sent her a link to my original episode, and I'll also link to it in the show notes for you.

But I promised her that I would do an episode updating the research.

And today I'm making good on that promise. Now first, let me just offer a quick recap for those who didn't hear my original episode.

Pendulam's glucose control probiotic was a proprietary blend of several different bacterial strains,

but the hero of this particular cocktail was a patented version of a bacterium known as acromancea.

This bacterial strain had only been identified in 2004, and it was Pendulam's research and

...